ResearchInnovating Kidney Care in Patients with Cancer: Development of an Inpatient Onconephrology Service
ResearchUrinary C-X-C-motif ligand 9 (CXCL9) in immune checkpoint inhibitor-associated acute interstitial nephritis
ResearchComparative safety of sodium-glucose co-transporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors in patients receiving anti-neoplastic therapies for cancer: An inverse probability treatment weighting analysis
ResearchUrine Cell-Free RNA vs Plasma Cell-Free RNA for Monitoring of Kidney Injury and Immune Complications
ResearchEculizumab Prophylaxis for Systematic Rechallenging Gemcitabine in Gemcitabine-Induced Thrombotic Microangiopathy: A Case Report
ResearchSerum Fibroblast Growth Factor 23 Levels as a Predictor of Acute Kidney Injury in Critically Ill Obstetric Women in Obstetric Intensive Care Units: A North Indian Study
ResearchRandomized trial of activated vitamin D for acute kidney injury prevention in critically ill patients
ResearchNephrotoxicity of Conventional Chemotherapeutics: Part II - Non-Platinum Agents and Miscellaneous Nephrotoxic Drugs
ResearchNephrotoxicity of Conventional Chemotherapeutics: Part I - Platinum Compounds and Antimetabolite Agents
ResearchSpatial Transcriptomics Identify T Cell-Driven Mechanisms of Kidney Damage in Immune Checkpoint Inhibitor-Associated Acute Interstitial Nephritis
ResearchThe nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroup
ResearchDerivation and external validation of a simple risk score for predicting severe acute kidney injury after intravenous cisplatin: cohort study
ResearchWe need more data to help guide the care of patients with cancer who develop kidney related problems